Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Return on Sales came in at 0.36% in Q1 2026, up 27.0% year-on-year from 0.28% in Q1 2025, and up 140.12% on a QoQ basis from 0.89% in Q4 2025.
Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 9 years of Return on Sales data on file, last reported at 0.36% in Q1 2026.
- On a quarterly basis, Return on Sales rose 27.0% year-over-year to 0.36% in Q1 2026; TTM through Mar 2026 was 0.03%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.03%, up 2.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.36%, up from 0.89% in the prior quarter.
- Over the last five years, Return on Sales for SLGL reached as high as 0.36% in Q1 2026 and fell as low as 5.09% in Q4 2022.
- Historically, Return on Sales has averaged 0.63% across 5 years, with a median of 0.11% in 2023.
- Across the five-year window, Return on Sales tumbled 510 bps in 2022 and jumped 390 bps in 2023, its largest moves.
- Year by year, Return on Sales stood at 5.09% in 2022, then surged by 77 bps to 1.19% in 2023, then slumped by 69 bps to 2.01% in 2024, then surged by 56 bps to 0.89% in 2025, then jumped by 140 bps to 0.36% in 2026.
- Per Business Quant data, the three most recent Return on Sales figures were 0.36% in Q1 2026, 0.89% in Q4 2025, and 0.16% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.36% |
| Dec 31, 2025 | -0.89% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.09% |
| Dec 31, 2024 | -2.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | -1.19% |
| Sep 30, 2023 | -0.30% |
| Jun 30, 2023 | -0.11% |
| Dec 31, 2022 | -5.09% |
| Sep 30, 2022 | -0.14% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.09% |
| Mar 31, 2021 | 0.06% |
| Dec 31, 2020 | -0.03% |